Winthrop Capital Management »

Alnylam Pharmaceuticals shares owned by Winthrop Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Winthrop Capital Management from 13F filings

Historical chart of Winthrop Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Winthrop Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Winthrop Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 5 200.00
2024-06-30 $1.0k 6 166.67
2024-03-31 $1.0k 6 166.67
2023-12-31 $1.1k 6 191.33

More positions owned by Winthrop Capital Management

Vanguard Information Technology Inf Tech Etf (VGT)
Spdr Portfolio Short Term Corporate Bond Portfolio Short (SPSB)
Invesco S&p 500 Equal Weight Etf S&p500 Eql Wgt (RSP)
Ishares Msci Usa Minimum Volatility Etf Msci (USMV)
Vanguard Financials Etf Financials Etf (VFH)
Ishares Core Msci Eafe Core (IEFA)
S&p 500 Index Tr Unit (SPY)
Vanguard Intermediate Corp Bond Etf Int-term Corp (VCIT)
Communications Services Select Sector Spdr Communication (XLC)
Health Care Select Sector Spdr Sbi Healthcare (XLV)
Spdr Portfolio High Yield Bond Etf Portfli High Yld (SPHY)
Nextera Energy (NEE)
Industrial Select Sector Spdr Etf Indl (XLI)
Consumer Discretionary Select Sector Spdr Sbi Cons Discr (XLY)
Sector Spdr Consumer Staples Sbi Cons Stpls (XLP)

View all positions for Winthrop Capital Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals